The Bottom Line – Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals. You may have heard of Recursion Pharmaceuticals in the media for its push to create 100 drug treatments in 10 years, focusing first on cures for rare diseases. The company’s approach is to combine drug repurposing efforts with artificial intelligence. Earlier this year, Chris sat down with Host Doug Wells to discuss this approach, and to delve deeper into the mission of Recursion Pharmaceuticals.
The Bottom Line was a business show that ran on KCPW from 2014 to 2017. Hosted by financial advisor Doug Wells, the show focused on the human story behind building and running a successful company in Utah, including the personal journey of founders and leaders, the hard work, the tough decisions, the temporary setbacks and
How do you feel about this topic?
Is there anything else you think we should know? We'd like to hear your thoughts. Send us your feedback using the form below.
